Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care.
Community pharmacy
Implementation
Medication review
Positive Deviance
Success factor
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
11
03
2021
accepted:
28
07
2021
pubmed:
7
8
2021
medline:
26
2
2022
entrez:
6
8
2021
Statut:
ppublish
Résumé
Background Pharmacists in community pharmacies worldwide successfully conduct an increasing number of medication reviews (MR). Since June 2012 MR are incorporated in the German ordinance on the operation of pharmacies as pharmaceutical service. In November 2014, a German guideline for MR was established. Different teaching programmes for MR were implemented since. Despite these favorable conditions, only few pharmacies conduct MR regularly. Identification of factors necessary for a successful implementation of MR in community pharmacies. Community pharmacies located in the area of the Pharmacists' Chamber Westphalia-Lippe (Part of Northrhine-Westphalia, Germany). Following a Positive-Deviance approach, telephone interviews were conducted in community pharmacies with pharmacy-owners, MR-trained employed pharmacists, and technicians. Data evaluation was performed using qualitative content analysis. Successful strategies for implementing MR in community pharmacies. Forty-four interviews were conducted and analysed. Thirty-three success factors were identified. Data analysis revealed two groups of success-factors important for implementation of MR; organisational (n = 25) and individual factors (n = 8). Relevant organisational success-factor were involvement of the entire team with active involvement of technicians, documentation of results in the pharmacy software and training in patient-identification and communication. Restructuring of workflows increased time-periods for MR. Important individual success-factors were: motivation and identification with the service, routine in execution to enhance self-esteem, and specialisation in pharmacotherapy of particular diseases. Pharmacy-owners play a pivotal role as motivators. Professional healthcare attitude, exhibited in daily routine, leads to increased acceptance by patients and practitioners and thus increases implementation-rates considerably. We were able to define strategies for successful implementation of MR in community pharmacies.
Identifiants
pubmed: 34357475
doi: 10.1007/s11096-021-01315-1
pii: 10.1007/s11096-021-01315-1
pmc: PMC8866257
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-89Informations de copyright
© 2021. The Author(s).
Références
BMJ Open. 2019 Jun 14;9(6):e026257
pubmed: 31201187
Implement Sci. 2009 May 08;4:25
pubmed: 19426507
Harv Bus Rev. 2000 Jan-Feb;78(1):14-5
pubmed: 10977192
Res Social Adm Pharm. 2018 Oct;14(10):883-890
pubmed: 29221929
Pharm World Sci. 2002 Dec;24(6):224-30
pubmed: 12512154
Health Policy. 2018 Mar;122(3):256-262
pubmed: 29113728
Int J Clin Pharm. 2013 Oct;35(5):813-20
pubmed: 23812680
J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):478-86
pubmed: 18647710
J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S7-S15.e5
pubmed: 29731422
N Z Med J. 2009 Apr 24;122(1293):3566
pubmed: 19448788
Res Social Adm Pharm. 2019 May;15(5):521-527
pubmed: 30139537
BMJ Qual Saf. 2016 Mar;25(3):190-201
pubmed: 26590198
BMC Pharmacol Toxicol. 2016 Aug 07;17(1):36
pubmed: 27497977
P T. 2015 Jan;40(1):56-61
pubmed: 25628508
Res Social Adm Pharm. 2020 Feb;16(2):123-141
pubmed: 31130436
Am J Infect Control. 2013 Nov;41(11):984-8
pubmed: 23973423
Ann Pharmacother. 2010 Mar;44(3):424-31
pubmed: 20179254
Can Fam Physician. 2008 Dec;54(12):1714-1717.e5
pubmed: 19074716
Pharm World Sci. 2009 Apr;31(2):188-94
pubmed: 19132542
Res Social Adm Pharm. 2009 Dec;5(4):347-62
pubmed: 19962678
Adv Health Sci Educ Theory Pract. 2012 Mar;17(1):95-105
pubmed: 21553153
Pharm World Sci. 2004 Oct;26(5):256-62
pubmed: 15598065
J Am Pharm Assoc (Wash). 2000 May-Jun;40(3):384-91
pubmed: 10853540
Br J Gen Pract. 2003 Aug;53(493):600-6
pubmed: 14601335
Dtsch Arztebl Int. 2016 Nov 4;113(44):741-748
pubmed: 27890050
Int J Clin Pharm. 2018 Oct;40(5):1199-1208
pubmed: 30073611
J Am Pharm Assoc (2003). 2018 Jan - Feb;58(1):9-11
pubmed: 29290345
Res Social Adm Pharm. 2017 Sep - Oct;13(5):938-946
pubmed: 28420595
Res Social Adm Pharm. 2012 May-Jun;8(3):206-16
pubmed: 21824822
Int J Clin Pharm. 2017 Jun;39(3):495-506
pubmed: 28315115
Drug Intell Clin Pharm. 1984 Dec;18(12):992-6
pubmed: 6510226
Can Pharm J (Ott). 2016 Sep;149(5):293-302
pubmed: 27708675
Health Serv Res. 2017 Jun;52(3):1207-1222
pubmed: 27349472
Int J Environ Res Public Health. 2018 Feb 10;15(2):
pubmed: 29439425
J Am Pharm Assoc (2003). 2007 Sep-Oct;47(5):620-8
pubmed: 17848353
Res Social Adm Pharm. 2014 Sep-Oct;10(5):731-40
pubmed: 24661800
Appl Clin Inform. 2018 Apr;9(2):391-402
pubmed: 29847843
Pharmacotherapy. 2000 Aug;20(8):991-1020
pubmed: 10939561